Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CANETGBP

(CANETGBP)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/28/202410:51PMPR Newswire (US)A school and a cable: A peek into China's people-centered reforms
07/28/202410:11PMPR Newswire (US)Bitget Wallet Achieves 34% New User Growth in Japan Market, Emerges as Second Largest Web3 Wallet after MetaMask
07/28/202410:07PMPR Newswire (Canada)Record $4.3 million raised for heart health in Alberta as children and Lauren Coughlin win big at CPKC Women's OpenNYSE:CPCanadian Pacific Kansas City Limited
07/28/202410:07PMPR Newswire (US)Record $4.3 million raised for heart health in Alberta as children and Lauren Coughlin win big at CPKC Women's OpenTSX:CPCanadian Pacific Kansas City Limited
07/28/202410:07PMPR Newswire (Canada)Record $4.3 million raised for heart health in Alberta as children and Lauren Coughlin win big at CPKC Women's OpenTSX:CPCanadian Pacific Kansas City Limited
07/28/202410:07PMPR Newswire (US)Record $4.3 million raised for heart health in Alberta as children and Lauren Coughlin win big at CPKC Women's OpenNYSE:CPCanadian Pacific Kansas City Limited
07/28/202410:00PMPR Newswire (US)Focusing on Southeast Asia, WEPACK ASEAN 2024 Creates a Brand-new Feast of Packaging Industry
07/28/20249:57PMPR Newswire (US)Bitget Wallet Achieves 34% New User Growth in Japan Market, Emerges as Second Largest Web3 Wallet after MetaMask
07/28/20249:29PMGlobeNewswire Inc.OKX Wallet Now Integrated with RootData
07/28/20249:15PMPR Newswire (US)Monster Energy's Belal Muhammad Defeats Leon Edwards to Claim UFC Welterweight Championship Title at UFC 304 In Manchester, England
07/28/20248:00PMBusiness Wirere.cogni.ze Study Shows: Digital Early Detection of Mild Cognitive Impairment (MCI) Suitable at All Levels of Medical Care – neotiv Reports
07/28/20248:00PMPR Newswire (US)Ghost Robotics Corporation and LIG Nex1 Announce Close of Acquisition
07/28/20247:41PMPR Newswire (Canada)Avis aux médias - Itinéraire de la vice-première ministre pour le lundi 29 juillet 2024
07/28/20247:39PMPR Newswire (Canada)Media Advisory - Deputy Prime Minister's itinerary for Monday, July 29, 2024
07/28/20247:00PMBusiness Wireアインがガバナンスと透明性に関する懸念を解決しない中、議決権行使助言会社は来るアインの定時株主総会におけるオアシスの提案を支持
07/28/20247:00PMBusiness WireOasis Secures Proxy Advisor Support for Upcoming Ain AGM as Ain Fails to Address Governance & Transparency Concerns
07/28/20246:05PMPR Newswire (US)Triukas Announces Launch of Asset Optimization Division
07/28/20246:00PMGlobeNewswire Inc.Vital Energy to Expand Delaware Basin Position Through Bolt-on AcquisitionNYSE:NOGNorthern Oil and Gas Inc
07/28/20246:00PMGlobeNewswire Inc.Vital Energy to Expand Delaware Basin Position Through Bolt-on AcquisitionNYSE:VTLEVital Energy Inc
07/28/20246:00PMBusiness WireNOG Announces Second Joint Acquisition with Vital Energy in the Delaware BasinNYSE:NOGNorthern Oil and Gas Inc
07/28/20246:00PMGlobeNewswire Inc."Chengdu's Exclusive Project Shines in Dubai, Setting the Standard for Global Lakeside Living"
07/28/20246:00PMPR Newswire (US)Unitywater selects Cognizant for Information and Communication Technology (ICT) Support Managed ServicesNASDAQ:CTSHCognizant Technology Solutions Corporation
07/28/20246:00PMPR Newswire (US)The consequences of ending abortion protection, the patient perspective on laboratory developed tests, health equity, and more to be explored at ADLM 2024
07/28/20245:43PMPR Newswire (Canada)Incendies de forêt - INTERDICTION DE FAIRE DES FEUX À CIEL OUVERT EN FORÊT OU À PROXIMITÉ
07/28/20245:00PMGlobeNewswire Inc.Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
07/28/20245:00PMPR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Monday, July 29, 2024
07/28/20245:00PMPR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le lundi 29 juillet 2024
07/28/20244:51PMGlobeNewswire Inc.Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)NASDAQ:LGVNLongeveron Inc
07/28/20244:51PMGlobeNewswire Inc.Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)NASDAQ:LGVNRLongeveron Inc
07/28/20244:33PMPR Newswire (Canada)LES TESTS SANGUINS POUR LA MALADIE D'ALZHEIMER POURRAIENT AMÉLIORER LE DIAGNOSTIC DANS LES SOINS PRIMAIRES, ACCÉLÉRER LE RECRUTEMENT POUR LA RECHERCHE ET RÉDUIRE LES TEMPS D'ATTENTE

Your Recent History

Delayed Upgrade Clock